CTN-0100-A-1: Discontinuing Buprenorphine: Patient Experiences (DC-BUPE)

Mat Kladney, MD
Principal Investigator
Grossman School of Medicine Bellevue Hospital
Department of Medicine New York University
mathew.kladney@nyulangone.org

This qualitative sub-study of the discontinuation phase of the CTN-0100 research study will examine the experiences of people who have attempted to stop buprenorphine for treatment of opioid use disorder to determine why some people are able to stop buprenorphine for treatment of opioid use disorder while others are not and identify risk factors for return to non-prescribed opioid use when someone is tapering off buprenorphine.

Related Studies

• CTN-0100: Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy

Related Resources

• Publications in the Library about CTN-0100-A-1
• NIDA protocol page

Node Involvement

Lead Node(s):

New York Node